Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Speech Language Pathology/Therapy Service | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Physical Therapy Medicine | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Occupational Therapy | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Occipital Nerve Stimulation | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Investigational Services & Procedures | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Investigational Services & Procedures | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Intraosseous Basivertebral Nerve Ablation | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Electrical Bone Growth Stimulation of the Appendicular Skeleton | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Dental Services Pediatric (Qualified Health Plans and Applicable Plans) | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Cosmetic and Reconstructive Procedures | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Cognitive Rehabilitation | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Chiropractic Services | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Blood and Blood Components, Platelet Derived Growth Factors and Prolotherapy | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Ambulance and Medical Transport Services (Ground, Air and Water) | Retired |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Treatment of Varicose Veins/Venous Insufficiency | New policy |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Transcutaneous Electrical Nerve Stimulation (TENS) | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Remote Electrical Neuromodulation for Migraines | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Percutaneous Electrical Nerve Field Stimulation for Functional Abdominal Pain Disorders | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Pediatric Neurodevelopmental & Autism Spectrum Disorder (ASD) Screening | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Nontraditional Biomarkers in Risk Assessment and MGMT of CVD | New policy |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Negative Pressure Wound Therapy in the Outpatient Setting | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Monitored Anesthesia Care (MAC) during Gastrointestinal Endoscopy, Bronchoscopy, or Interventional Procedures in Outpatient Settings | New policy |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Ketamine | New policy |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Intraosseous Basivertebral Nerve Ablation | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Hospital Beds | New policy |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Genetic and Genomic Testing for the Diagnosis and Management of Select Cancers and Genetic Diseases | New policy |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Electrical Bone Growth Stimulation of the Appendicular Skeleton | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Drug Testing in Pain Management and Substance Use Disorder | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Cytochrome P450 Genotype-Guided Treatment Strategy | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Cytochrome P450 Genotype-Guided Treatment Strategy | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Cochlear Implant and Implantable Bone Conduction Hearing Aids | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Clinical Trials | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Autologous Chondrocyte Transplantation or Implantation | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Allergy Testing, including Selected Blood, Serum and Cellular Testing and Toxicity Testing | Metadata changed |
| Oct 24, 2026 | Blue Cross and Blue Shield of Vermont | Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynotoses | New policy |
| Oct 24, 2026 | Premera Blue Cross | 3.01.521 (effective October 9, 2026) Psychiatric and Other Specified | Retired |
| Oct 24, 2026 | Premera Blue Cross | 7.01.63 Deep Brain Stimulation | Retired |
| Oct 24, 2026 | Premera Blue Cross | 10.01.535 (effective January 1, 2026) Enhanced Dental Care Benefit | New policy |
| Oct 24, 2026 | Premera Blue Cross | 3.01.521 (effective November 16, 2026) Psychiatric and Other | New policy |
| Oct 24, 2026 | Premera Blue Cross | 7.01.594 (effective January 1, 2027) Percutaneous Revascularization | New policy |
| Oct 24, 2026 | Premera Blue Cross | 2.04.521 (effective November 6, 2026) Evaluation of Cerebrospinal | Metadata changed |
| Oct 24, 2026 | Premera Blue Cross | 2.01.106 (effective November 6, 2026) Percutaneous Electrical | Metadata changed |
| Oct 24, 2026 | Premera Blue Cross | 11.01.526 (effective January 1, 2027) Site of Service Ambulatory | New policy |
| Oct 24, 2026 | Premera Blue Cross | 5.01.647 (effective January 1, 2027) Medical Necessity Criteria | New policy |
| Oct 24, 2026 | Premera Blue Cross | 5.01.620 (effective January 1, 2027) Vascular Endothelial Growth | New policy |
| Oct 24, 2026 | Premera Blue Cross | 7.01.601 (effective November 6, 2026) Endovascular Stent Grafts | Metadata changed |
| Oct 24, 2026 | Premera Blue Cross | 5.01.517 (effective January 1, 2027) Use of Vascular Endothelial | New policy |
| Oct 24, 2026 | Premera Blue Cross | 7.01.160 (effective November 6, 2026) Cartilage Implants for | Metadata changed |
| Oct 24, 2026 | Premera Blue Cross | 5.01.512 Botulinum Toxin | Metadata changed |
| Oct 24, 2026 | Premera Blue Cross | 5.01.629 (effective January 1, 2027) Pharmacologic Treatment | New policy |